Gene One Life Science Inc (011000) Stock Price & News

All values in KRW	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	5.08B	2.65B	2.58B	2.06B
Cost of goods sold	8.86B	9.09B	2.56B	8.78B
Cost of revenue	8.86B	9.09B	2.56B	8.78B
Research and development expenses	659.29M	289.06M	5.93M	315.30M
Total research and development expenses	-	-	-	-
Selling, general, and admin expenses	5.19B	4.30B	2.03B	2.45B
Operating expense	7.88B	6.69B	2.36B	8.14B
Total operating expenses	16.74B	15.78B	4.92B	16.92B
Operating income	-11.66B	-13.12B	-2.34B	-14.86B
Other non operating income	743.26M	8.19M	-6.40M	-2.96B
EBT including unusual items	-11.48B	-16.24B	-2.38B	-18.95B
EBT excluding unusual items	-11.52B	-16.24B	-2.38B	-18.89B
Income tax expense	-7.89M	-100.93M	-	-
Effective tax rate	0.07%	0.62%	-	-
Other operating expenses	178.87M	130.87M	16.68M	18.10M
Net income	-11.47B	-16.14B	-2.38B	-18.95B
Net profit margin	-225.92%	-608.48%	-92.29%	-921.57%
Earnings per share	-	-	-	-
Interest and investment income	33.38M	87.93M	48.23M	270.06M
Interest expense	-647.78M	-3.20B	-211.98M	-1.29B
Net interest expenses	-614.40M	-3.12B	-163.75M	-1.02B
Depreciation and amortization charges	1.76B	1.81B	295.04M	2.99B
EBITDA	-7.22B	-8.56B	-2.04B	-7.05B
Gain or loss from assets sale	-39.28M	-4.55M	-	54.01M

Finance